[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?]

Huriet, C; Megerlin, F

[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?] / Cov19, études de séroprévalence et Comités de protection des personnes : n'ajoutons pas une charge administrative au défi technologique et organisationnel.

Huriet, C; Megerlin, F.

Huriet C; Membre honoris causa de l'Académie nationale de médecine, Paris, France.
Megerlin F; Membre de l'Académie nationale de pharmacie, Paris, France; Centre d'études internationales et européennes EA 7307/CNRS FR 3241, université de Strasbourg, Strasbourg, France. Electronic address: megerlin@unistra.fr.

Ann Pharm Fr ; 78(4): 285-286, 2020 07.

Article in French | MEDLINE | ID: covidwho-663996

Subject(s)

COVID-19/epidemiology; Seroepidemiologic Studies; Antibodies/analysis; COVID-19 Testing; France; Humans; Public Health; Quarantine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Seroepidemiologic Studies / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: Europa Language: French Journal: Ann Pharm Fr Year: 2020 Document Type: Article Affiliation country: J.pharma.2020.04.001

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google